Natco Pharma Ltd. NSE: NATCOPHARM | BSE: 524816

Strong Performer, Under Radar

Download real time

868.85 -6.25 (-0.71%)

46.99% Fall from 52W High

296.0K

NSE+BSE Volume

NSE 23 Jun, 2025 2:17 PM (IST)

US FDA Observation

Natco Pharma gets Form 483 with 7 observation from the US FDA for its Pharma facility in Hyderabad See details

Natco Pharma Ltd. News, Corporate filings and Earnings/Conference Calls

Name: Latest research reports of Natco Pharma Ltd. authored by Geojit BNP Paribas and published by - Trendlyne research reports.
Item: Natco Pharma Ltd.
Rating: 3
Author: Geojit BNP Paribas

Keep track of all breaking news and updates on Natco Pharma Ltd. from all sources in a single place.

Load latest

Is Natco Pharma Ltd. worth buying?

541 Votes:

Buy 83.18%

Sell 7.39%

Hold 9.43%

RESEARCH REPORTS

Hold SEE REPORTS >

pdf

Hold SEE REPORTS >

pdf